A systematic literature review of cerebrospinal fluid biomarkers in delirium

Dementia and Geriatric Cognitive Disorders

Volumn 32, Issue 2, 2011, Pages 79-93

  Hall, Roanna J ^a,b   Shenkin, Susan D ^a,b   MacLullich, Alasdair M J ^a,b  

^a School of Clinical Sciences and Community Health   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Biomarkers; Cerebrospinal fluid; Cortisol; Cytokines; Delirium; Neurotransmitters

Indexed keywords

BETA ENDORPHIN; BIOLOGICAL MARKER; DOPAMINE; HYDROCORTISONE; INTERLEUKIN 8; PROTEIN; SEROTONIN; SOMATOSTATIN;

CEREBROSPINAL FLUID ANALYSIS; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SYSTEMATIC REVIEW;

ACETYLCHOLINESTERASE; BETA-ENDORPHIN; BIOLOGICAL MARKERS; BRAIN; DELIRIUM; DOPAMINE; HUMANS; HYDROCORTISONE; INTERLEUKIN-8; LACTIC ACID; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; SOMATOSTATIN;

EID: 80052082635     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000330757     Document Type: Review

References (77)

1. Siddiqi N, House A, Holmes J: Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 2006; 35: 350-364. (Pubitemid 43941802)
2. MacLullich A, Ferguson K, Miller T, de Rooij S, Cunningham C: Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 2008; 65: 229-238.
3. Young J, Inouye S: Delirium in older people. BMJ 2008; 334: 842-846. (Pubitemid 46706931)
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Washington, APA, 2000.
5. Rockwood K, Cosway S, Carver D, Jarrett P, Stadnyk K, Fisk J: The risk of dementia and death after delirium. Age Ageing 1999; 28: 551-556. (Pubitemid 29535333)
6. MacLullich A, Beaglehole A, Hall R, Meagher D: Delirium and long-term cognitive impairment. Int Rev Psychiatry 2009; 21: 30-42.
7. Flacker J, Lipsitz L: Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol 1999; 54A:B239-B246. (Pubitemid 29319295)
8. Olsson T: Activity in the hypothalamic-pituitary- adrenal axis and delirium. Dement Geriatr Cogn Dis 1999; 10: 345-349. (Pubitemid 29403593)
9. Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D, Moher D, Becker B, Sipe T, Thacker S: Meta-analysis of observational studies in epidemiology - a proposal for reporting. J Am Med Assoc 2000; 283: 2008-2012. (Pubitemid 30214957)
10. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Organisation, 1992.
11. Inouye S, Vandyck C, Alessi C, Balkin S, Siegal A, Horowitz R: Clarifying confusion - the confusion assessment method - a new method for detection of delirium. Ann Intern Med 1990; 113: 941-948.
12. Sanderson S, Tatt I, Higgins J: Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007; 36: 666-676. (Pubitemid 47244573)
13. MacLullich A, Edelshain B, Hall R, de Vries A, Howie S, Pearson A, Middleton S, Gillies F, Armstrong I, White T, Cunningham C, de Rooij S, van Munster B: Cerebrospinal IL-8 levels are higher in hip fracture patients with delirium versus controls. J Am Geriatr Soc 2011; 59: 1151-1153.
14. Tanaka K, Mitsushio H, Isse K: A clinical study of prostaglandin D 2 in cerebrospinal fluid of elderly patients with delirium. Ann Rep Pharmacopsychiat Res Found 1993; 24: 14-21.
15. Tanaka K: Increased levels of prostaglandin D 2 in cerebrospinal fluid of elderly patients with delirium. Jpn J Psychiatry Neurol 1993; 47: 695-696.
16. Koponen H, Lepola U, Leinonen E: A longterm follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium. Eur Arch Psychiatry Clin Neurosci 1994; 244: 131-134. (Pubitemid 24284957)
17. Koponen H, Sirvio J, Reinikainen K, Riekkinen P: A longitudinal study of cerebrospinal fluid acetylcholinesterase in delirium: changes at the acute stage and at one-year follow-up. Psychiatry Res 1991; 38: 135-142.
18. Koponen H, Riekkinen P: A long-term follow- up study of cerebrospinal fluid beta-endorphin- like immunoreactivity in delirium: changes at the acute stage and at one-year follow-up. Acta Psychiatr Scand 1990; 82: 323-326. (Pubitemid 20335844)
19. Koponen H, Stenback U, Mattila E, Reinikainen K, Soininen H, Riekkinen P: CSF beta- endorphin-like immunoreactivity in delirium. Biol Psychiatry 1989; 25: 938-944. (Pubitemid 19122769)
20. Koponen H, Stenback U, Mattila E, Reinikainen K, Soininen H, Riekkinen P: Cerebrospinal fluid somatostatin in delirium. Psychol Med 1989; 19: 605-609. (Pubitemid 19243707)
21. Koponen H, Reinikainen K, Riekkinen P: Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up. Psychol Med 1990; 20: 501-505. (Pubitemid 20374815)
22. Koponen H, Leinonen E, Lepola U, Riekkinen P: A long-term follow-up study of cerebrospinal fluid somatostatin in delirium. Acta Psychiatr Scand 1994; 89: 329-334. (Pubitemid 24157954)
23. Koponen H, Sirvio J, Lepola U, Leinonen E: A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium. Eur Arch Psychiatry Clin Neurosci 1994; 243: 347-351. (Pubitemid 24147012)
24. Ramirez-Bermudez J, Ruiz-Chow A, Perez- Neri I, Soto-Hernandez J, Flores-Hernandez R, Nente F, Montes S, Rios C: Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. Gen Hosp Psychiatry 2008; 30: 337-343. (Pubitemid 351862311)
25. Pearson A, de Vries A, Middleton S, Gillies F, White T, Armstrong I, Andre R, Seckl J, MacLullich A: Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes 2010; 3: 33.
26. Caplan G, Kvelde T, Lai C, Yap S, Lin C, Hill M: Cerebrospinal fluid in long-lasting delirium compared with Alzheimer's dementia. J Gerontol A Biol Med Sci 2010; 65: 1130-1136.
27. Secin R, Esponda J, Rivera B: Validacion del Delirium Rating Scale (DRS) en espanol en una unidad de cuidados intensivos. Psiquis 1998; 7: 7-14.
28. Trzepacz P, Baker R, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988; 23: 89-97. (Pubitemid 18038426)
29. Ramirez-Bermudez J, Camilo R, Perez-Neri I, Sergio M, Francisco N, Chow A: Neurochemical markers of delirium in cerebrospinal fluid of neurological patients with delirium. 26th Collegium Internationale Neuro- Psychopharmacologicum Congress (CINP), Int J Neuropsychopharmacol 2008; 11: 296-296.
30. Kudoh A, Takese H, Katagai H, Takazawi T: Postoperative interleukin-6 and cortisol concentrations in elderly patients with postoperative confusion. Neuroimmunomodulation 2005; 12: 60-66. (Pubitemid 40528911)
31. McIntosh T, Bush H, Yeston N, Grasberger R, Palter M, Aun F, Egdahl R: Beta-endorphin. Cortisol and postoperative delirium: a preliminary report. Psychoneuroendocrinology 1985; 10: 303-313. (Pubitemid 16237739)
32. Seehusen D, Reeves M, Fomin D: Cerebrospinal fluid analysis. Am Fam Physician 2003; 68: 1103-1108. (Pubitemid 37173831)
33. von Elm I: Assessing the quality of observational studies - or a lesson from Mars. Int J Epidemiol 2007; 36: 677-678.
34. Inouye S, Ferrucci L: Elucidating the pathophysiology of delirium and the interrelationship of delirium and dementia. J Gerontol Med Sci 2006; 61A:1277-1280. (Pubitemid 46151069)
35. Murakami K, Nakagawa T, Shozu M, Uchide K, Koike K, Inoue M: Changes with aging of steriodal levels in the cerebrospinal fluid of women. Maturitas 1999; 33: 71-80. (Pubitemid 29469720)
36. Otte C, Hart S, Neylan T, Marmar C, Yaffe K, Mohr D: A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005; 30: 80-91. (Pubitemid 39195047)
37. Ginaldi L, Mengoli L, De Martinis M: Review on immunosenescence. Rev Clin Gerontol 2008; 17: 161-169. (Pubitemid 352006194)
38. Ballabh P, Braun A, Nedergaard M: The blood-brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13. (Pubitemid 38569790)
39. Davies D: Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002; 200: 639-646. (Pubitemid 34823055)
40. Petzold A: CSF biomarkers for improved prognostic accuracy in acute CNS disease. Neurol Res 2007; 29: 691-708. (Pubitemid 350086068)
41. Karkela J, Pasanen M, Kaukinen S, Morsky P, Harmoinen A: Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate and pyruvate. Crit Care Med 1992; 20: 378-386.
42. Parnetti L, Reboldi G, Gallai V: Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology 2000; 54: 735-737. (Pubitemid 30082948)
43. Fillenz M: The role of lactate in brain metabolism. Neurochem Int 2005; 47: 413-417. (Pubitemid 41242622)
44. White S: The neuropathogenesis of delirium. Rev Clin Gerontol 2002; 12: 62-67.
45. van der Mast R, Fekkes D, Moleman P, Pepplinkhuizen L: Is postoperative delirium related to reduced plasma tryptophan? Lancet 1991; 338: 851-852.
46. Pandharipande P, Morandi A, Adams J, Girard T, Thompson J, Shintani A, Ely E: Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients Intensive Care Med 2009; 35: 1886-1892.
47. Trzepacz P: Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5: 132-148.
48. Talesa V: Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 2001; 122: 1961-1969.
49. Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Systemat Rev 2006;CD005593.
50. White S, Calver B, Newsway V, Wade R, Patel S, Bayer A, O'Mahoney M: Enzymes of drug metabolism during delirium. Age Ageing 2005; 34: 603-608. (Pubitemid 41700004)
51. Vecsai L, Widerlov E: Preclinical and clinical studies with somatostatin related to the central nervous system. Prog Neuropsychopharmacol Biol Psychiat 1990; 14: 473-502. (Pubitemid 20272343)
52. Murray R, Kim K, Ren S-G, Chelly M, Umehara Y, Melmed S: Central and peripheral actions of somatostatin on the growth hormone- IGF-1 axis. J Clin Investigat 2004; 114: 349-356. (Pubitemid 39071607)
53. Broadhurst C, Wilson K: Immunology of delirium: new opportunities for treatment and research. Br J Psychiatry 2001; 179.
54. Adamis D, Lunn M, Martin FC, Treloar A, Gregson N, Hamilton G, MacDonald AJD: Cytokines and IGF-1 in delirious and nondelirious acutely ill older medical inpatients. Age Ageing 2009; 38: 326-332.
55. Wilson K, Broadhurst C, Diver M, Jackson M, Mottram P: Plasma insulin-like growth factor-1 and incident delirium. Int J Geriatr Psychiatry 2005; 20: 154-159. (Pubitemid 40277894)
56. Wollemann M, Benyhe S: Non-opioid actions of the opioid peptides. Life Sci 2004; 75: 257-270.
57. O'Donahue T, Dorsa D: The opiomelanotropinergic neuronal and endocrine systems. Peptides 1982; 3: 353-395. (Pubitemid 12022681)
58. Zager E, Black P: Neuropeptides in human memory and learning processes. Neurosurgery 1985; 17: 355-369. (Pubitemid 15014032)
59. Jolkkonen J, Soininen H, Riekkinen P: Betaendorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's dementia and Parkinson's disease. J Neurol Sci 1987; 77: 153-159. (Pubitemid 17231290)
60. Sulkava R, Erkinjuntti T, Laatikainen T: CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia. Neurology 1985; 35: 1057-1058.
61. Raskind M, Peskind E, Lampe T, Risse S, Taborsky G, Dorsa D: Cerebrospinal fluid vasopressin, oxytocin, somatostatin and betaendorphin in Alzheimer's disease. Arch Gen Psychiatry 1986; 43: 382-388. (Pubitemid 16056780)
62. Munhoz C, Sorrells S, Caso J, Scavone C, Sapolsky R: Glucocorticoids exacerbate lipopolysaccharide- induced signaling in the frontal cortex and hippocampus in a dosedependent manner. J Neurosci 2010; 30: 13690-13698.
63. Perry V, Cunningham C, Holmes C: Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 2007; 7: 161-167. (Pubitemid 46174862)
64. 2+ currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 2001; 78: 960-971. (Pubitemid 32823145)
65. Platasalaman C, Borkoski J: Interleukin-8 modulates feeding by direct action in the central nervous system. Am J Physiol 1993; 265:R877-R882.
66. Hussein M, Daoud G, Kakita H, Kato S, Goto T, Kamei M, Goto K, Nobata M, Ozaki Y, Ito T, Fukuda S, Kato I, Suzuki S, Sobajima HF, Hashimoto T, Togari H: High cerebrospinal fluid antioxidants and interleukin 8 are protective of hypoxic brain damage in newborns. Free Rad Res 2010; 44: 422-429.
67. Hanson J, Bostick M, Campe C, Kodali P, Lee G, Yan J, Maher J: Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity. J Hepatol 2006; 44: 359-367. (Pubitemid 43069218)
68. Holt R, Siddiqi N, Young J: The ethics of consent in delirium studies. J Psychosom Res 2008; 65: 283-287.
69. Zetterberg H: Biomarkers reflecting different facets of Alzheimer's dementia. Eur J Neurol 2008; 15: 1143-1144.
70. Schwarz E, Bahn S: Cerebrospinal fluid: identification of diagnostic markers for schizophrenia. Expert Rev Mol Diagn 2008; 8: 209-216. (Pubitemid 351469440)
71. Gudmundsson P, Skoog I, Waern M, Blennow K, Zetterberg H, Rosengren L, Gustafson D: Is there a CSF biomarker profile related to depression in elderly women? Psychiatry Res 2010; 176: 174-178.
72. Regenold W, Phatak P, Marano C, Sassan A, Conley R, Kling M: Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 2009; 65: 489-494.
73. Awad A, Hemmer B, Hartung H-P, Kieseier B, Bennett J, Stuve O: Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol 2010; 219: 1-7.
74. van Everbroeck B, Boons J, Cras P: Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2005; 107: 355-360. (Pubitemid 40980377)
75. Hyland K: Clinical utility of monoamine neurotransmitter metabolite analysis in cerebrospinal fluid. Clin Chem 2008; 54: 633-641. (Pubitemid 351573703)
76. Frolich L, Dirr A, Gotz M, Gsell W, Reichmann H, Riederer P, Maurer K: Acetylcholine in human CSF: methodological considerations and levels in dementia of the Alzheimer type. J Neural Transm 1998; 105: 961-973. (Pubitemid 28539840)
77. Bender M: Kinetics of cholinesterase in blood and spinal fluid. Am J Physiol 1939; 126: 180-187.